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Abstract
Early detection and treatment of skin cancer can significantly improve patient outcome. However,
present standards for diagnosis require biopsy and histopathologic examinations that is relatively
invasive, expensive and difficult for patients with many early stage lesions. Here we show an
oblique incidence diffuse reflectance spectroscopic (OIDRS) system that can be used for rapid
skin cancer detection in vivo. This system was tested under clinical conditions by obtaining
spectra from pigmented and non-pigmented skin lesions, including melanomas, differently staged
dysplastic nevi and common nevi that were validated by standard patho-histological criteria. For
diagnosis of pigmented melanoma, the data obtained achieved 90% sensitivity and specificity for a
blinded test set. In a second analysis, we demonstrated that this spectroscopy system can also
differentiate non-pigmented basal cell or squamous cell carcinomas from non-cancerous skin
abnormalities such as actinic keratoses and seborrheic keratoses, achieving 92% sensitivity and
specificity. Taken together, our findings establish how oblique incidence diffuse reflectance
spectrometry can be used to more rapidly and easily diagnose skin cancer in an accurate and
automated manner in the clinic.
1. Introduction
Skin cancer is the most common form of cancer, with about a million new cases in the U.S.
each year [1]. Often, skin cancer is difficult to diagnose non-invasively, as malignant skin
lesions can closely resemble their benign counterparts. Different lesion types can have
similar characteristics, furthering the problem in discriminating among them. Among all the
skin lesions, melanoma is the most malignant type and is the leading cause of death from the
skin diseases.
The American Cancer Society estimates that there will be approximately 62,000 new cases
of melanoma in the U.S. this year, with about 8,000 deaths [1]. Melanoma can be mistaken
for common nevi, dysplastic nevi, and seborrheic keratoses (SK). Common nevi are benign
moles formed by a cluster of melanocytes in the basal layer of the epidermis or in the top
layers of the dermis. Dysplastic nevi are moles with atypical size, shape, or organization.
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Depending on the degrees of atypia, dysplastic nevi can be mild, moderate, or severe.
Dysplastic nevi are more likely than common nevi to develop into melanomas [2]. Finally,
seborrheic keratoses (SK) are benign wart-like tumors that are very common in people over
forty.
In addition to melanoma, skin cancers also include squamous cell carcinomas and basal cell
carcinomas. Squamous cell carcinomas (SCC) arise from dividing keratinocytes of the
epidermis, and are often recognized by hyperkeratotic crusts or scales or by ulceration in the
later stages. Actinic keratosis (AK), a precancerous skin tumor caused by sun exposure, can
in some cases turn into squamous cell carcinoma, which in invasive cases may metastasize
to local nodes and beyond [3]. Basal cell carcinomas (BCC) are derived from keratinocytes
[4]. BCCs are locally invasive, slow-growing tumors characterized by islands or nests of
basal keratinocytes invading the dermis. There are several clinical and histologic subtypes of
basal cell carcinomas. Superficial BCCs are papulosquamous lesions characterized by red,
scaly raised plaques.
Early detection and treatment of skin cancer can significantly improve patient outcomes. In
clinical practice, visual examination determines whether a skin lesion is cancerous based on
the ABCDE rule (asymmetry, border, color, diameter and evolution) and the change in the
appearance of a mole or pigmented area over a period of time. However, clinical diagnostic
sensitivity and specificity vary greatly, depending on the expertise and visual skills of the
clinician. Consequently, histopathologic examination of the excised suspicious element still
remains the gold standard. However, biopsy is an invasive procedure and leaves a scar at the
biopsy site, which otherwise would be unnecessary in the case of benign lesions. Moreover,
the removal of every lesion can be unacceptable for patients with large numbers of skin
abnormalities, such as in dysplastic nevi syndrome.
Changes in the cell nuclear matrix have been associated with cell and tissue structures which
are important features in the diagnosis of cancer [5,6]. Morphological changes in tumor cells
include alterations of nuclear structure such as changes in nuclear size and shape [5]. These
alterations are important characteristics used in cancer diagnosis. Cell nuclei, mitochondria,
other cytoplasmic organelles and cell nuclei, are the major light scatterers in the skin tissue.
In malignant tissues, larger atypical nuclei and larger cell volume are a main cause for the
significant increase in the light scattering [7]. For example, the reduced scattering
coefficient has been shown to generally increase with the degree of dysplasia or malignancy
of skin lesions [8].
Recently, non-invasive spectroscopic methods for tissue diagnosis have been studied for a
number of organ systems, including the skin [9-19], gastrointestinal tract [20-24], cervix
[25-27], and breast [28-30]. The absorption of light can provide information of the
biochemical composition of the skin. The light scattering properties of skin can provide
information regarding its micro-architecture [31]. Fluorescence spectroscopy can detect
disease states [32,33]. Because fluorescence is a manifestation of the biochemical
environment of the cell, it should be a specific indicator of cellular alterations due to disease
[34]. Some studies also suggest that Raman spectroscopy can detect changes in protein and
lipid structure that can be used to diagnose skin tumors [35]. In this paper, we report the use
of spatially resolved oblique incidence diffused reflectance spectroscopy (OIDRS) as a non-
invasive tool to discriminate melanoma and non-melanoma skin cancer from benign and
premalignant skin lesions in vivo. Spatio-spectral diffuse reflectance data within the
wavelength range of 455–765 nm was collected from multiple types of pigmented and non-
pigmented skin lesions (n = 678). The data was used in combination with artificial neural
network (ANN) analysis to separate skin cancers such as pigmented malignant melanoma
and non-pigmented basal cell and squamous cell carcinomas from their benign counterparts.
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Neural networks are particularly helpful for classification. ANN classifiers are more
powerful than common statistical classifiers because they do not need hypothesis about data
distribution, linearity or correlations [36]. ANNs provide better prediction accuracy and
higher sensitivity and specificity with optimal use of the available information.
2. Methods
Fig. 1 is a schematic of the experimental OIDRS system. The system was built onto a
portable cart; it was easily moved to the patient exam rooms. To target both small and large
skin lesions, we constructed an optical fiber probe using micromachining technology. The
probe consisted of three source fibers and two linear arrays of 12 collection fibers within an
area of 2×2 mm2. To conduct OIDRS measurements on skin lesions, the optical probe was
placed gently on the skin area of interest without significant compression. The optical
multiplexer delivered light through only one oblique source fiber at a time to the area of
interest. Once the light was delivered to the skin, it interacted with the skin tissue, and the
spatially resolved diffuse reflectance was collected by one set of collection fibers. The
collection fibers were coupled to an imaging spectrograph that generated an optical
spectrum from 455 to 765 nm for the collection channel. A CCD camera collected the
spectral images, which were stored on a computer for data analysis. The data collection
takes less than 5 minutes, and it did not interfere with the standard healthcare provided to the
patients.
Data was collected at the University of Texas M.D. Anderson Cancer Center in Houston,
TX. A physician identified the lesion(s) to be measured before the scheduled biopsy. To
average out the effect of structural anisotropy of the skin tissue, the measurement of each
lesion was repeated four times to obtain images from different orientations. To provide self-
references, the same measurements were also repeated on the neighboring healthy skin
tissues. The anisotropy is defined as the variation of the measurements when performed in
different directions. After the measurements were completed, a biopsy was performed for
each skin lesion and submitted for histopathological analysis. The histopathological analysis
determined that the measured pigmented lesions consisted of benign common nevi (CN),
mildly dysplastic nevi (DN1), moderately dysplastic nevi (DN2), severely dysplastic nevi
(DN3), and melanomas (M). The criteria used to divide dysplastic nevi into these tree
categories is described in ref. [37]. Of the 407 pigmented skin lesions, 271 were used for the
training sets of ANN classifiers (Tables I and II) to separate malignant melanoma from
varieties of nevi. The remaining 136 data sets were used to test the efficacy of the ANN
classifiers. The non-pigmented lesions consisted of basal cell carcinomas (BCC), squamous
cell carcinomas (SCC), benign actinic keratoses (AK), and seborrheic keratoses (SK).
Among the 266 non-pigmented lesions, 177 were used to train the ANN classifier, and the
remaining 89 were used for testing.
3. Results
The absorption coefficient (μa) and reduced scattering coefficient (μs’) of the skin lesions
from the measured diffuse reflectance were estimated based on a combination of both
diffusion theory and scalable Monte Carlo simulation [38,39]. Since the optical transport
mean free path (Lt’) is a function of the wavelength of the incident light, the location of the
detectors may fall either within or outside the range of Lt’ at different wavelengths within
the wide spectrum (455 – 765 nm). At certain wavelengths, when the location of the
detectors falls outside the range of Lt’, the absorption and scattering optical properties of the
skin lesion can be directly calculated from diffuse reflectance using a straightforward
diffusion-theory based analytical model. However, this model would fail at other
wavelengths when the detector location falls within Lt’. In this case, scalable Monte Carlo
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simulation was conducted to deduce the absorption and scattering optical properties of the
skin lesions in an inverse problem by calculating and matching the simulated diffuse
reflectance results with the actual measurements.
The optical properties of human skin vary significantly between locations and individuals,
dependent on race, age, sun exposure, and skin type. Figs. 2a and 2b show the absorption
coefficient (μa) for the statistically significant skin types included in this study. We reduced
these variations by measuring and subtracting the optical priorities from the surrounding
healthy skin for each lesion. The differential absorption coefficient spectrum is defined as
(1)
where μa(λ)L and μa(λ)N are the absorption coefficient spectra measured from the lesion
and from the normal surrounding skin, respectively. In a similar way the differential reduced
scattering coefficient is defined as
(2)
Fig. 2 shows the average absorption coefficient μa(λ)L, differential absorption coefficient
Δμa(λ), reduced scattering coefficient μs’(λ) L, and differential reduced scattering
coefficient Δμs’(λ) for melanoma, dysplastic nevi and common nevi, respectively.
The diffuse reflectance of tissue is related largely to absorption and scattering.
Mitochondria, cell nuclei, and other cytoplasmic organelles are known changeable
parameters in cancerous tissues and are major light scatterers in skin tissue [40,41].
Although no single histologic variable specifically distinguishes these types of pigmented
lesions, nuclear atypia seems directly related to the amount of light scattering. Dysplastic
nevi are characterized by nuclear enlargement, slight irregularity, and hyperchromasia, with
clumping of chromatin and sometimes with prominent nucleoli. Dysplastic nevi present
atypical features that are both clinically and histologically important as simulants of
melanoma. Like other cancers, most malignant melanomas evolve through a number of
stages of tumor progression. Clinically, many melanomas begin as a pigmented patch of skin
which evolves to become a palpable plaque, and enlarges as if it were along the radii of an
imperfect circle [42]. Variably sized and shaped nests and single melanocytes are present in
the epidermis in a pagetoid pattern characteristic of superficial melanoma. Prognosis has
long been known to correlate with melanoma thickness as measured microscopically. These
factors can increase the contribution of scattering to the diffuse reflection on the surface.
A one-way ANOVA test was performed to compare μa(λ)L for common nevi, dysplastic
nevi, and melanoma. The p-value was significant (p<0.01) in the spectral region between
488 and 576 nm. Pairwise comparisons using Tukey’s test showed a significant difference
only between common nevi and melanoma. A similar analysis for μs’(λ)L shows a
significant difference of at least one mean for the entire wavelength range (455-765 nm).
The ANOVA test of the Δμa(λ) showed statistical difference in the range between 455 and
599 nm, with the lowest p-value at 556 nm (p=0.00063). The pairwise comparisons revealed
that Δμa(λ) from 549 to 556 nm presented a significant difference among the three types of
lesions. This spectral region corresponds to an absorption peak in deoxy-hemoglobin. These
results showed the importance of subtracting the optical properties of the surrounding
healthy skin for each lesion in order to reduce the variations due to differences in skin type
and condition. The ANOVA and Tukey’s tests of Δμs’(λ) show a significant difference
among the three types of lesions when using the spectral range between 455 and 765 nm.
Both squamous-cell carcinomas (SCC) and basal-cell carcinomas (BCC) presented on
average a higher differential reduced scattering coefficient than actinic keratosis (AK), and
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seborrheic keratosis (SK) (Fig. 3). An ANOVA and Tukey’s test of μa(λ)L revealed no
significant difference among all four types of lesions. However the ANOVA test of Δμa(λ)
showed a p-value that indicates a significant difference (p<0.01) in the spectral region 455–
633 nm with the lowest p=0.0008 at 577 nm. The absorption coefficient spectra for SKs
have the largest variation (Fig. 3). The subtraction of the reference absorption coefficients
from the lesions’ absorption coefficients reduces the overlap among the types of lesions and
resulted in a statistically significant difference between AK, SCC, and BCC. The pairwise
comparison of Δμs’(λ) between AK with SK, AK with SCC, SK with BCC, and SK with
SCC in the wavelength range between 455 and 765 nm was statistically significant.
This higher light scattering in cancerous cases can be explained by the larger average
effective size of the scattering centers. SCC in-situ has not yet penetrated through the
basement membrane of the dermoepidermal junction. SCCs typically appear as scaling
plaques with sharply defined red color. Histologically, all epidermal layers may contain
atypical keratinocytes. The larger amount of atypical keratinocytes in SCC can increase the
light scattering in this type of skin lesion and significantly affect its contribution to diffusely
reflected light on the surface. SCC may penetrate the basement membrane to become
invasive. More advanced, invasive SCCs may appear clinically as hyperkeratosis and may
ulcerate [43], which can affect the measurements of optical properties. To avoid this
problem, we performed the measurements in areas that did not present this condition.
Actinic keratosis (AK) may appear rough and scaly and may develop into a SCC.
Histologically, AKs are recognized by the presence of atypical keratinocytes in the deeper
portions of the epidermis. Defective maturation of the superficial epidermal layers results in
parakeratosis alternating with hyperkeratosis [43,44]. During the data collection, we avoided
areas that presented hyperkeratosis. The amounts of atypical keratinocytes and collagen are
factors related to the amount of light scattering in the lesion.
Basal cell carcinomas (BCC) are derived from the basal layer of keratinocytes, the deepest
cell layer of the epidermis. BCCs can present nodular aggregates of basalioma cells in the
dermis and exhibit peripheral palisading and retraction artifacts. Melanin can also be present
in the tumor and in the surrounding stroma, as observed in pigmented basal cell carcinoma.
The aggregation of basalioma cells can increase the light scattering in these types of
malignant lesions. The progression of seborrheic keratosis into basal cell carcinoma and
squamous cell carcinoma is rare [45,46]. However, SKs can clinically resemble SCCs, and
for this reason SKs are commonly removed or biopsied for histopathologic examination
[47]. SKs, composed of basaloid cells admixed with some squamoid cells, can be pigmented
when some cells contain melanin transferred from neighboring melanocytes.
The classifications of the skin lesions were performed directly for the measured diffuse-
reflectance spectra. The advantage of using these direct measurements is that no
homogeneity assumption is required. To design the classifiers, first we selected features
from the diffuse-reflectance spectra that effectively separated the malignant group from the
benign group. The nature of the acquired diffuse-reflectance spectra and what they represent
played a role in determining their effectiveness. The characteristics of the diffuse reflectance
data indicate that particular spectral regions have higher separability among the different
classes. We employed the continuous wavelet transform (CWT) to extract the most effective
features in the two classes under analysis [10]. Based on the features, we investigated the
use of multiple classification schemes to separate the skin lesions into clinically significant
categories (benign, pre-cancerous, and cancerous) as identified by their clinical and
histopathologic diagnoses. The most successful classification scheme was ANN in
combination with a genetic algorithm (GA). For the pigmented and non-pigmented lesion
groups, we classified the lesions into two classes at a time and repeated this for the
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subgroups until we achieved the desired degree of categorization. Fig. 4 illustrates the
hierarchical classification system for pigmented lesions. This particular classification
scheme intrinsically emphasizes the primary importance of accurate classification of
melanoma and severe dysplastic nevi. Each stage consists of a single classifier. In the first
stage, melanoma is separated from the other lesions. In a similar way, in each stage the most
“malignant” type lesion is separated from the remaining categories.
Tables I present the confusion matrixes for the training and testing sets, where the row
headers show the ground truths from the histopathologic diagnosis and the column headers
indicate the OIDRS classifications. The classification process in the testing set achieved
90% sensitivity and specificity for melanoma detection. Table II shows the sensitivity and
specificity for each classifier in the hierarchical classification scheme. The minimum
sensitivity is 89%, which corresponds to the classifiers that separate mild dysplastic nevi
form benign common nevi. Sensitivity indicates the percentage of correctly identified
positives (true positives) and specificity measures the proportion of negatives which are
correctly identified.
For the non-pigmented group, a single ANN classifier separated BCC and SCC from AK
and SK. The designed classifier generated a sensitivity of 97% and a specificity of 96%.
Table III and V show the classification results for non-pigmented lesions. For the testing set
the sensitivity ands specificity were both 92 %.
5. Conclusions
This study established that it is feasible to use oblique incidence diffuse reflectance
spectroscopy (OIDRS) as a potential tool for in vivo discrimination of malignant cutaneous
melanoma from other types of pigmented skin lesions. In a clinical trial, OIDRS
distinguished malignant melanoma with 90% sensitivity and specificity for the testing set.
The sensitivity and specificity for the training set were 100% and 95%, respectively. This
system has also successfully classified basal cell carcinomas and squamous cell carcinomas
with 92% sensitivity and specificity. The sensitivity and specificity for the training set were
97% and 96%, respectively. Light scattering events inside the skin tissues change
significantly with the development stage of the skin lesion. This change in the tissue
scattering properties in the diffuse reflectance spectrum forms a physiological basis for
automated classification of different skin lesions based on OIDRS measurements.
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Fig. 1.
A schematic of the experimental OIDRS system.
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Fig. 2.
(a) Average absorption coefficient spectra μa(λ), and (b) average reduced scattering
coefficient for skin types 1, 2 and 3 estimated from 47, 816, and 44 lesions, respectively, (c)
Average absorption coefficient spectra, (d) average reduced scattering coefficient spectra,
(e) average differential absorption coefficient spectra, and (f) average differential reduced
scattering coefficient spectra for common nevi, dysplastic nevi, and melanoma. The error
bars represent standard errors.
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Fig. 3.
(a) Average absorption coefficient spectra, (b) average reduced scattering coefficient
spectra, (c) average differential absorption coefficient spectra, and (d) average differential
reduced scattering coefficient spectra for squamous-cell carcinoma (SCC), basal-cell
carcinoma (SCC), actinic keratosis (AK), and seborrheic keratosis (SK). The error bars
represent standard errors.
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Fig. 4.
The classification scheme for pigmented lesions.
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Table III
Non-pigmented lesions confusion matrix.
Predicted
Actual
BCC/SCC AK/SK Total
Training
BCC (n=78) /SCC (n=49) 123 4 127
AK (n=38)/SK (n=12) 2 48 50
Testing
BCC (n=39)/SCC (n=25) 59 5 64
AK (n=19)/SK (n=6) 2 23 25
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